US Stock MarketDetailed Quotes

CAPR Capricor Therapeutics

Watchlist
  • 5.050
  • 0.0000.00%
Trading Apr 19 13:42 ET
159.09MMarket Cap-6084P/E (TTM)

About Capricor Therapeutics Company

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Company Profile

SymbolCAPR
Company NameCapricor Therapeutics
Listing DateMar 9, 2015
Founded1996
CEODr. Linda Marban, PhD
MarketNASDAQ
Employees102
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address10865 Road to the Cure,Suite 150
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-727-1755
Websitehttp://www.capricor.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Linda Marban, PhD
  • President, Chief Executive Officer and Director
  • 747.32K
  • Anthony J. Bergmann, M.B.A.
  • Principal Accounting Officer and Chief Financial Officer
  • 730.85K
  • Karen G. Krasney, J.D.
  • Executive Vice President, General Counsel and Secretary
  • 740.77K
  • Dr. Frank Litvack,M.D.
  • Executive Chairman of the Board
  • 759.55K
  • Dr. Philip Gotwals,PhD
  • Director
  • 467.36K
  • Michael Kelliher
  • Director
  • 681.38K
  • Dr. Paul Gisbert Auwaerter, M.D.
  • Director
  • --
  • Karimah Es Sabar
  • Independent Director
  • 196.14K
  • George W. Dunbar,Jr
  • Independent Director
  • 211.13K
  • David B. Musket
  • Independent Director
  • 237.36K
  • Earl M. Collier, Jr
  • Independent Director
  • 222.37K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg